Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Core Lab Reports Third Quarter 2020 Results From Continuing Operations:

      - COMPANY REVENUE OF $105.4 MILLION; DOWN 9% SEQUENTIALLY

      - GAAP EPS OF $0.07; $0.16, EX-ITEMS

      - CORE GENERATES FCF FOR 76TH CONSECUTIVE QUARTER OF $18.5 MILLION

      - CORE REDUCES NET DEBT BY $16.2 MILLION

      - CORE ANNOUNCES $60 MILLION OF 5-YEAR & 7-YEAR PRIVATE PLACEMENT NOTES

      Core Laboratories N.V. logo (PRNewsFoto/Core Laboratories N.V.)

      News provided by

      Core Laboratories N.V.

      Oct 21, 2020, 17:15 ET

      Share this article

      Share this article


      AMSTERDAM, Oct. 21, 2020 /PRNewswire/ -- Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") ("Core", "Core Lab", or the "Company") reported that continuing operations resulted in third quarter 2020 revenue of $105,400,000. Core's operating income was $11,300,000, with earnings per diluted share ("EPS") of $0.07, all in accordance with U.S. generally accepted accounting principles ("GAAP").  Operating income, ex-items, a non-GAAP financial measure, was $12,300,000, yielding operating margins of 12% and EPS, ex-items, of $0.16.  A full reconciliation of non-GAAP financial measures is included in the attached financial tables.

      Continue Reading
      This graph summarizes the maximum leverage ratio permitted over the relevant period.
      This graph summarizes the maximum leverage ratio permitted over the relevant period.

      The sequential decline in revenue was attributable to continued global industry disruptions associated with COVID-19, as well as four tropical weather systems impacting the Gulf of Mexico during the third quarter of 2020.  Geographically, the sequential revenue decline was primarily associated with a decrease in both international product sales, as well as lower activity on international projects.  Improved revenue from the U.S. land market was offset by Gulf Coast storm-related disruptions.  

      Previously announced Cost Reduction Plans (Phase 1 and Phase 2), totaling $61,000,000 of annualized cost savings, have now been fully implemented and were completed in the third quarter of 2020, in line with Core's previously stated expectations.  Core's management will continue to evaluate further options to align the Company's cost structure with anticipated client activity as necessary.

      Core's CEO, Larry Bruno stated, "Core's third quarter results display both the durability and adaptability of the business model, along with the benefit of our cost reduction plans, as Core continued to generate free cash flow despite the aforementioned industry disruptions.  Core's global exposure, talented and dedicated staff, along with our expanding line of proprietary and patented products and services, have us well positioned to navigate today's market and capitalize on future opportunities".

      Liquidity, Free Cash Flow, Private Placement Notes and Dividend

      During the third quarter of 2020, Core continued to generate free cash flow ("FCF"), with cash from operations of $20,700,000 and incurred capital expenditures of $2,200,000, yielding FCF of $18,500,000.  The third quarter of 2020 marks the 76th consecutive quarter that the Company generated positive FCF, despite challenging market and industry conditions.  Free cash was almost entirely focused towards reducing the Company's debt, with net debt reduced by $16,200,000 during the third quarter of 2020.  Core will continue applying its excess free cash flow towards debt reduction for the foreseeable future. 

      As previously announced on 16 October 2020, Core Lab entered into an agreement to issue $60,000,000 of new fixed-rate long-term senior notes ("Notes") through a private placement to extend the maturity for a portion of the Company's long-term debt.  The Note Purchase Agreement was signed on 16 October 2020, with funding to occur 12 January 2021.

      The following table summarizes the terms of the new Notes:

      Instrument


      Face Value

      ($ Millions)



      Term


      Interest
      Coupon



      Maturity Date

      U.S. Private Placement Notes


      $

      45.0



      5-Year


      4.09%



      12 January 2026

      U.S. Private Placement Notes



      15.0



      7-Year


      4.38%



      12 January 2028

      TOTAL


      $

      60.0










      The net proceeds from the new Notes are intended to be used exclusively to reduce outstanding debt on the Company's revolving credit facility ("Credit Facility"), thus increasing the available borrowing capacity by $60,000,000. The Company's Credit Facility has an aggregate borrowing capacity of $225,000,000, of which $116,000,000 was outstanding as of 30 September 2020.  The Company's CFO, Chris Hill, had the following statement, "This transaction accomplishes two goals as we manage the Company's corporate debt structure through the disruptions associated with the COVID-19 pandemic.  First, it provides additional liquidity under the Company's Credit Facility to address the outstanding $75 million senior notes maturing 30 September 2021, and second, issuing $60 million in new Notes and retiring $75 million of existing notes next year is an additional step toward our long-term strategy of reducing debt and Core Lab's debt leverage ratio". The new Notes include certain financial covenants that align with the financial covenants under the Company's Credit Facility, limiting total Company net debt to a maximum leverage ratio and requiring a minimum interest coverage ratio.

      Quarter Ending 2020 2021 Jun. 30 Sept. 30 Dec. 31 Mar. 31 Jun. 30 Sept. 30 Dec. 31 Maximum Leverage Ratio 3.00 2.75 2.50 2.00 1.50 1.00 Core Lab's leverage ratio of 2.21 at 30 June 2020

      As of 30 September 2020, the Company's leverage ratio was 2.49 to 1, with $96,000,000 of excess capacity under the Credit Facility.  As stated earlier, the proceeds from the new Notes on 12 January 2021 are intended to reduce outstanding debt on the Company's Credit Facility and provide an additional $60,000,000 of borrowing capacity and liquidity.  The Company anticipates it will continue to generate positive cash flow and reduce net debt, while maintaining ample liquidity. 

      On 17 July 2020, the Board announced a quarterly cash dividend of $0.01 per share of common stock, which was paid on 10 August 2020 to shareholders of record on 27 July 2020.  Dutch withholding tax was deducted from the dividend at a rate of 15%.

      On 15 October 2020, the Board announced a quarterly cash dividend of $0.01 per share of common stock, payable on 17 November 2020 to shareholders of record on 26 October 2020.  Dutch withholding tax will be deducted from the dividend at a rate of 15%.

      Reservoir Description

      Reservoir Description revenue in the third quarter of 2020 was $80,100,000, down 9% sequentially. Operating income for the third quarter of 2020 on a GAAP basis was $11,000,000, while operating income, ex-items, was $11,700,000, yielding operating margins, ex-items, of 15%, down slightly more than 200 BPS sequentially. Revenue, operating income, and margins were all affected by both continued COVID-19 project disruptions and weather events in the Gulf of Mexico during the third quarter of 2020.  Implemented cost controls in the segment helped mitigate the impact to operating margins.

      Core's clients continue to be heavily focused on digital transformation technologies to pursue operational excellence.  Core Lab has been at the forefront of this movement for more than two decades.  Core's extensive, proprietary databases and analog technologies, coupled with artificial intelligence ("AI") and machine learning, help the Company's clients improve efficiencies and lower operating costs throughout the upstream value chain. In the third quarter of 2020, Core Lab's Digital Innovation Group worked collaboratively with multiple international and national oil companies on projects that utilize several of Core's proprietary digital technologies and services.  Core's proprietary Advanced Rock Typing technology combines Core's vast, comprehensive database of physical measurements, and Rock CatalogsTM with its proprietary image acquisition technology and the latest in AI image recognition.  These technologies provide clients with analog data sets in situations where acquisition of new conventional core may not be possible.  High-resolution images of wellbore cuttings and sidewall cores are quickly and efficiently matched with analogs from Core's proprietary database of samples from around the world.  Physically measured data sets from the matching analogs are delivered to Core's clients in time to make appraisal and development decisions.

      During the third quarter of 2020, Core Laboratories, under the direction of The CarbonNet Project ("CarbonNet") engaged in laboratory analysis of 300 feet of conventional core from the Gular-1 appraisal well in the offshore Gippsland Basin, in the Bass Strait, off the southeast coast of Australia.  CarbonNet is funded by the Victorian and Commonwealth governments of Australia.  In a recent press release the CarbonNet team mentioned, "The CarbonNet Project is advancing the science and viability for establishing a commercial-scale carbon capture and storage ("CCS") network. The network would bring together multiple carbon dioxide ("CO2") capture projects in Victoria's Latrobe Valley, transporting CO2 via a shared pipeline and injecting it into deep, underground, offshore storage sites in the Bass Strait.  CCS is being investigated as part of a suite of solutions with the potential to mitigate greenhouse gas emissions." The cores are progressing through physical laboratory measurements, in an iterative analytical program.  The data generated by Core Lab will provide insight into seal capacity, storage capacity, geomechanical properties and the pore system properties of the rock.  Core Laboratories is pleased to be playing a role in evaluating this important CCS project, which is among the most promising CO2 storage opportunities in the region. 

      Production Enhancement

      Production Enhancement operations, which are focused on complex completions in unconventional, tight-oil reservoirs in the U.S., as well as conventional offshore projects across the globe, posted third quarter 2020 revenue of $25,300,000, declining 7% sequentially.  The revenue decline was primarily associated with decreased international product shipments due to COVID-19 disruptions and weather events in the Gulf of Mexico.  More positively, U.S. land revenue increased 23% sequentially, partially mitigating the sequential decline in international sales, and correlating favorably with the improved U.S. land well completion activity during the quarter.  Operating loss on a GAAP basis was $300,000, and approximately break-even, ex-items.   Although revenue sequentially declined in the third quarter as compared to the second quarter of 2020, the operating loss was minimized, and improved significantly, as a result of cost-control measures completed during the second and third quarters of 2020. 

      During the third quarter of 2020, Core Lab introduced its next generation, best-in-class, HERO®PerFRAC energetic technology, which is now available in combination with the new, patent pending Oriented GoGun™. This new technology provides Core's clients with a technological solution for achieving: 1) extreme limited entry perforating capability, 2) precisely aligned perforations, and 3) minimized connections and completion string length.  Casing erosion around perforations can occur when stimulating unconventional reservoirs.  Larger perforating holes preferentially increase in size and take more frac fluid, robbing stimulation from smaller perforating holes, which results in inconsistent breakdown of the formation. The consistent-sized holes generated by the latest HERO®PerFRAC charges reduce this problem.  Core Lab partnered with major U.S. operators to design custom, consistent-hole-size charges that can be aligned in a specific orientation in order to achieve uniform breakdown across each stage.  Core Lab's Production Enhancement development team designed a patent pending method to orient the GoGun™, with both very high accuracy and wellsite efficiency. By eliminating the need for reusable orientation subassemblies, the Oriented GoGun™ minimizes the number of connections and saves time at the wellsite by not having to recapture and redress the orienting subs. 

      Also during the third quarter of 2020, Core Lab's Production Enhancement engineers developed and introduced a new application for its proprietary SpectraChem® chemical frac water tracer to determine whether horizontal wells are unobstructed and flowing through the entire length of the lateral.  Leveraged by operators in the Permian, Eagle Ford, and Haynesville, this technology can identify wellbore obstructions, often caused by inter-well communication or dissolvable plug remnants.  By applying this technology, Core's clients can identify and remediate well obstructions that can negatively impact well performance, reserve calculations and reserve-based lending.

      Return On Invested Capital

      Core's Board of Supervisory Directors ("Board") and the Company's Executive Management continue to focus on strategies that maximize return on invested capital ("ROIC") and FCF, a non-GAAP financial measure defined as cash from operations less capital expenditures, factors that have high correlation to total shareholder return.  Core's commitment to an asset-light business model and disciplined capital stewardship promote capital efficiency and are designed to produce more predictable and superior long-term ROIC.

      Events associated with the COVID-19 pandemic have caused significant disruptions in global markets and economies, with adverse effects throughout the energy sector. These adverse effects have triggered significant asset impairments for goodwill, intangible assets, inventory and other fixed assets, which further distort underlying financial performance and performance metrics, such as ROIC.

      The Board has established an internal performance metric of demonstrating superior ROIC performance relative to the oilfield service companies listed as Core's Comp Group by Bloomberg.  In the first half of 2020, Core Lab recorded $133 million in non-cash charges associated with the impairments and inventory write-down.  Excluding these non-cash asset impairments and write-down, Bloomberg's calculation of Core's ROIC was 4.3%.  Under the current circumstances, and considering the magnitude of the asset and goodwill impairment charges incurred across the energy industry, it is difficult to appropriately determine the underlying relative performance across the Bloomberg Comp Group as compared with Core Lab.

      Industry and Core Lab Outlook

      Conversations with Core's clients broadly reaffirm the Company's expectation that international projects already underway will continue; however, the pace and breadth of recovery from COVID-19 restrictions remains uncertain, making it difficult to forecast both the level and timing of such activity.  Core Lab projects international activity in the fourth quarter of 2020 may slightly to modestly improve sequentially for both operating segments, if COVID-19 travel restrictions and supply chain disruptions begin to ease. 

      Within Reservoir Description, Core expects reservoir fluid analysis, which accounts for more than 65% of the segment's revenue, to be more resilient as this work is diversified across the life of reservoir and less reliant on drilling and completion of new wells.

      U.S. land activity improved from the lows experienced during the middle of the second quarter as the third quarter of 2020 unfolded.  This trend of gradual improvement in U.S. land activity is expected to continue into the fourth quarter of 2020.  As a result, Core Lab projects overall fourth quarter 2020 U.S. land activity to modestly improve sequentially, and expects Production Enhancement to continue to track or outperform activity levels in U.S. land completions.

      Collectively, these trends point toward slightly to modestly improved sequential operational performance for Core Lab, barring any COVID-19-related retrenchments in client activity.  Additionally, Core expects to generate positive FCF in the fourth quarter of 2020 as Core's aggressive adjustments to its cost structure further align with client activity, with continued focus on free cash generation and strategic debt reduction.   

      Earnings Call Scheduled

      The Company has scheduled a conference call to discuss Core's third quarter 2020 earnings announcement. The call will begin at 7:30 a.m. CDT / 2:30 p.m. CEST on Thursday, 22 October 2020. To listen to the call, please go to Core's website at www.corelab.com.

      Core Laboratories N.V. is a leading provider of proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum reservoir performance.  The Company has over 70 offices in more than 50 countries and is located in every major oil-producing province in the world. This release, as well as other statements we make, includes forward-looking statements regarding the future revenue, profitability, business strategies and developments of the Company made in reliance upon the safe harbor provisions of Federal securities law.  The Company's outlook is subject to various important cautionary factors, including risks and uncertainties related to the oil and natural gas industry, business conditions, international markets, international political climates, public health crises, such as the COVID-19 pandemic, and any related actions taken by businesses and governments, and other factors as more fully described in the Company's most recent Forms 10-K, 10-Q and 8-K filed with or furnished to the U.S. Securities and Exchange Commission.  These important factors could cause the Company's actual results to differ materially from those described in these forward-looking statements. Such statements are based on current expectations of the Company's performance and are subject to a variety of factors, some of which are not under the control of the Company. Because the information herein is based solely on data currently available, and because it is subject to change as a result of changes in conditions over which the Company has no control or influence, such forward-looking statements should not be viewed as assurance regarding the Company's future performance. The Company undertakes no obligation to publicly update or revise any forward-looking statement to reflect events or circumstances that may arise after the date of this press release, except as required by law.

      Visit the Company's website at www.corelab.com. Connect with Core Lab on Facebook, LinkedIn and YouTube.


      CORE LABORATORIES N.V. & SUBSIDIARIES

      CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

      (amounts in thousands, except per share data)

      (Unaudited)




      Three Months Ended



      % Variance





      September 30,
      2020



      June 30,
      2020



      September 30,
      2019



      vs. Q2-20



      vs. Q3-19



      REVENUE


      $

      105,382



      $

      115,736



      $

      173,200



      (8.9)%



      (39.2)%

























      OPERATING EXPENSES:






















      Costs of services and sales



      81,038




      90,680




      125,996



      (10.6)%



      (35.7)%



      General and administrative expense



      8,937




      9,221




      11,012



      (3.1)%



      (18.8)%



      Depreciation and amortization



      5,164




      5,425




      5,697



      (4.8)%



      (9.4)%



      Inventory write-down



      —




      9,932




      —



      NM



      NM



      Other (income) expense, net



      (1,088)




      3,045




      (712)



      NM



      NM



      Total operating expenses



      94,051




      118,303




      141,993



      (20.5)%



      (33.8)%

























      OPERATING INCOME (LOSS)



      11,331




      (2,567)




      31,207



      NM



      (63.7)%



      Interest expense



      4,672




      3,369




      3,662



      38.7%



      27.6%



      Income (loss) from continuing operations

         before income tax expense



      6,659




      (5,936)




      27,545



      NM



      (75.8)%



      Income tax expense (benefit)



      3,663




      (261)




      3,335



      NM



      9.8%



      Income (loss) from continuing operations



      2,996




      (5,675)




      24,210



      NM



      (87.6)%



      Income (loss) from discontinued

         operations, net of income taxes



      —




      —




      (397)



      NM



      NM



      Net income (loss)



      2,996




      (5,675)




      23,813



      NM



      (87.4)%



      Net income (loss) attributable to non-

         controlling interest



      33




      41




      84



      (19.5)%



      (60.7)%



      Net income (loss) attributable to Core

         Laboratories N.V.


      $

      2,963



      $

      (5,716)



      $

      23,729



      NM



      (87.5)%

























      Diluted EPS (loss per share) from continuing operations


      $

      0.07



      $

      (0.13)



      $

      0.54



      NM



      (87.0)%

























      Diluted EPS (loss per share) attributable to Core

         Laboratories N.V.


      $

      0.07



      $

      (0.13)



      $

      0.53



      NM



      (86.8)%

























      Weighted average diluted common

         shares outstanding



      44,899




      44,470




      44,716



      1.0%



      0.4%

























      Effective tax rate



      55

      %



      4

      %



      12

      %


      NM



      NM

























      SEGMENT INFORMATION:












































      Revenue:






















      Reservoir Description


      $

      80,060



      $

      88,442



      $

      109,339



      (9.5)%



      (26.8)%



      Production Enhancement



      25,322




      27,294




      63,861



      (7.2)%



      (60.3)%



      Total


      $

      105,382



      $

      115,736



      $

      173,200



      (8.9)%



      (39.2)%

























      Operating income (loss):






















      Reservoir Description


      $

      11,022



      $

      13,534



      $

      18,835



      (18.6)%



      (41.5)%



      Production Enhancement



      (321)




      (16,324)




      11,456



      NM



      NM



      Corporate and Other



      630




      223




      916



      NM



      NM



      Total


      $

      11,331



      $

      (2,567)



      $

      31,207



      NM



      (63.7)%

























      "NM" means not meaningful






















      CORE LABORATORIES N.V. & SUBSIDIARIES

      CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

      (amounts in thousands, except per share data)

      (Unaudited)




      Nine Months Ended



      % Variance





      September 30,
      2020



      September 30,
      2019







      REVENUE


      $

      373,518



      $

      511,432



      (27.0)%

















      OPERATING EXPENSES:














      Costs of services and sales



      286,849




      377,830



      (24.1)%



      General and administrative expense



      37,725




      38,250



      (1.4)%



      Depreciation and amortization



      16,030




      17,070



      (6.1)%



      Inventory write-down and impairments



      132,136




      —



      NM



      Other (income) expense, net



      987




      2,653



      (62.8)%



      Total operating expenses



      473,727




      435,803



      8.7%

















      OPERATING INCOME (LOSS)



      (100,209)




      75,629



      NM



      Interest expense



      11,452




      11,102



      3.2%



      Income (loss) from continuing operations before income tax expense



      (111,661)




      64,527



      NM



      Income tax expense (benefit)



      (644)




      (19,467)



      NM



      Income (loss) from continuing operations



      (111,017)




      83,994



      NM



      Income (loss) from discontinued operations, net of income taxes



      —




      7,833



      NM



      Net income (loss)



      (111,017)




      91,827



      NM



      Net income (loss) attributable to non-controlling interest



      157




      174



      (9.8)%



      Net income (loss) attributable to Core Laboratories N.V.


      $

      (111,174)



      $

      91,653



      NM

















      Diluted EPS (loss per share) from continuing operations


      $

      (2.50)



      $

      1.87



      NM

















      Diluted EPS (loss per share) attributable to Core Laboratories N.V.


      $

      (2.50)



      $

      2.04



      NM

















      Weighted average diluted common shares outstanding



      44,470




      44,854



      (0.9)%

















      Effective tax rate



      1

      %



      (30)

      %


      NM

















      SEGMENT INFORMATION:




























      Revenue:














      Reservoir Description


      $

      271,203



      $

      318,280



      (14.8)%



      Production Enhancement



      102,315




      193,152



      (47.0)%



      Total


      $

      373,518



      $

      511,432



      (27.0)%

















      Operating income (loss):














      Reservoir Description


      $

      35,618



      $

      40,892



      (12.9)%



      Production Enhancement



      (137,944)




      31,792



      NM



      Corporate and Other



      2,117




      2,945



      NM



      Total


      $

      (100,209)



      $

      75,629



      NM

















      "NM" means not meaningful














      CORE LABORATORIES N.V. & SUBSIDIARIES

      CONDENSED CONSOLIDATED BALANCE SHEET

      (amounts in thousands)

      (Unaudited) 
















      % Variance



      ASSETS:


      September 30,
      2020



      June 30,
      2020



      December 31,
      2019



      vs. Q2-20



      vs. Q4-19

























      Cash and cash equivalents


      $

      15,146



      $

      20,958



      $

      11,092



      (27.7)%



      36.5%



      Accounts receivable, net



      85,366




      101,464




      131,579



      (15.9)%



      (35.1)%



      Inventory



      42,908




      41,528




      50,163



      3.3%



      (14.5)%



      Other current assets



      26,469




      27,443




      28,403



      (3.5)%



      (6.8)%



      Total Current Assets



      169,889




      191,393




      221,237



      (11.2)%



      (23.2)%

























      Property, plant and equipment, net



      117,123




      119,866




      123,506



      (2.3)%



      (5.2)%



      Right-of-use assets



      69,228




      70,147




      75,697



      (1.3)%



      (8.5)%



      Intangibles, goodwill and other long-term assets, net



      234,574




      233,035




      354,233



      0.7%



      (33.8)%



      Total assets


      $

      590,814



      $

      614,441



      $

      774,673



      (3.8)%



      (23.7)%

























      LIABILITIES AND EQUITY:












































      Accounts payable


      $

      22,806



      $

      23,693



      $

      35,611



      (3.7)%



      (36.0)%



      Short-term operating lease obligations



      11,807




      12,028




      11,841



      (1.8)%



      (0.3)%



      Current maturities of long-term debt



      75,000




      —




      —



      NM



      NM



      Other current liabilities



      62,523




      63,563




      64,142



      (1.6)%



      (2.5)%



      Total current liabilities



      172,136




      99,284




      111,594



      73.4%



      54.3%

























      Long-term debt, net



      189,566




      286,610




      305,283



      (33.9)%



      (37.9)%



      Long-term operating lease obligations



      56,649




      57,449




      64,660



      (1.4)%



      (12.4)%



      Other long-term liabilities



      100,754




      104,951




      110,996



      (4.0)%



      (9.2)%

























      Total equity



      71,709




      66,147




      182,140



      8.4%



      (60.6)%



      Total liabilities and equity


      $

      590,814



      $

      614,441



      $

      774,673



      (3.8)%



      (23.7)%




      "NM" means not meaningful

      CORE LABORATORIES N.V. & SUBSIDIARIES

      CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

      (amounts in thousands)

      (Unaudited)




      Three Months Ended





      September 30,
      2020



      June 30,
      2020



      September 30,
      2019



      CASH FLOWS FROM OPERATING ACTIVITIES














      Income (loss) from continuing operations


      $

      2,996



      $

      (5,675)



      $

      24,210



      Income (loss) from discontinued operations



      —




      —




      (397)



      Net Income (loss)


      $

      2,996



      $

      (5,675)



      $

      23,813



      Adjustments to reconcile net income to net cash provided by operating activities:














      Stock-based compensation



      2,859




      2,865




      3,311



      Depreciation and amortization



      5,164




      5,425




      5,697



      Deferred income tax



      (5,460)




      (180)




      (3,353)



      Inventory write-down



      —




      9,932




      —



      Adjustment to gain on sale of discontinued operations



      —




      —




      397



      Accounts receivable



      16,157




      24,288




      (2,603)



      Inventory



      (1,582)




      987




      (4,287)



      Accounts payable



      (1,051)




      (12,343)




      815



      Other adjustments to net income (loss)



      1,610




      1,697




      2,199



      Net cash provided by operating activities


      $

      20,693



      $

      26,996



      $

      25,989

















      CASH FLOWS FROM INVESTING ACTIVITIES














      Capital expenditures


      $

      (2,172)



      $

      (3,066)



      $

      (5,307)



      Proceeds from sale of discontinued operations



      —




      —




      (1,853)



      Other investing activities



      (202)




      (206)




      (437)



      Net cash used in investing activities


      $

      (2,374)



      $

      (3,272)



      $

      (7,597)

















      CASH FLOWS FROM FINANCING ACTIVITIES














      Repayment of debt borrowings


      $

      (25,000)



      $

      (26,000)



      $

      (28,000)



      Proceeds from debt borrowings



      3,000




      10,000




      35,000



      Dividends paid



      (445)




      (445)




      (24,399)



      Repurchase of treasury shares



      (157)




      (198)




      (411)



      Other financing activities



      (1,529)




      (13)




      —



      Net cash used in financing activities


      $

      (24,131)



      $

      (16,656)



      $

      (17,810)

















      NET CHANGE IN CASH AND CASH EQUIVALENTS



      (5,812)




      7,068




      582



      CASH AND CASH EQUIVALENTS, beginning of period



      20,958




      13,890




      12,546



      CASH AND CASH EQUIVALENTS, end of period


      $

      15,146



      $

      20,958



      $

      13,128



      CORE LABORATORIES N.V. & SUBSIDIARIES

      CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

      (amounts in thousands)

      (Unaudited)




      Nine Months Ended





      September 30,
      2020



      September 30,
      2019



      CASH FLOWS FROM OPERATING ACTIVITIES










      Income (loss) from continuing operations


      $

      (111,017)



      $

      83,994



      Income (loss) from discontinued operations



      —




      7,833



      Net Income (loss)


      $

      (111,017)



      $

      91,827



      Adjustments to reconcile net income to net cash provided by operating activities:










      Stock-based compensation



      16,254




      17,652



      Depreciation and amortization



      16,030




      17,070



      Deferred income tax



      (13,014)




      (38,469)



      Inventory write-down and impairments



      132,136




      —



      Gain on sale of business



      —




      (1,154)



      Gain on sale of discontinued operations



      —




      (8,411)



      Accounts receivable



      45,229




      (8,924)



      Inventory



      (2,880)




      (7,202)



      Accounts payable



      (13,262)




      1,762



      Other adjustments to net income (loss)



      238




      4,074



      Net cash provided by operating activities


      $

      69,714



      $

      68,225













      CASH FLOWS FROM INVESTING ACTIVITIES










      Capital expenditures


      $

      (8,578)



      $

      (17,537)



      Proceeds from sale of business



      —




      2,980



      Proceeds from sale of discontinued operations



      —




      14,789



      Other investing activities



      (952)




      (775)



      Net cash used in investing activities


      $

      (9,530)



      $

      (543)













      CASH FLOWS FROM FINANCING ACTIVITIES










      Repayment of debt borrowings


      $

      (71,000)



      $

      (96,000)



      Proceeds from debt borrowings



      30,000




      103,000



      Dividends paid



      (12,001)




      (73,168)



      Repurchase of treasury shares



      (1,593)




      (1,502)



      Other financing activities



      (1,536)




      —



      Net cash used in financing activities


      $

      (56,130)



      $

      (67,670)













      NET CHANGE IN CASH AND CASH EQUIVALENTS



      4,054




      12



      CASH AND CASH EQUIVALENTS, beginning of period



      11,092




      13,116



      CASH AND CASH EQUIVALENTS, end of period


      $

      15,146



      $

      13,128



      Non-GAAP Information

      Management believes that the exclusion of certain income and expenses enables it to evaluate more effectively the Company's operations period-over-period and to identify operating trends that could otherwise be masked by the excluded Items.  For this reason, we use certain non-GAAP measures that exclude these Items; and we feel that this presentation provides a clearer comparison with the results reported in prior periods. The non-GAAP financial measures should be considered in addition to, and not as a substitute for, the financial results prepared in accordance with GAAP, as more fully discussed in the Company's financial statement and filings with the Securities and Exchange Commission.

      Reconciliation of Operating Income, Income from Continuing Operations and Earnings Per
      Diluted Share from Continuing Operations

      (amounts in thousands, except per share data)

      (Unaudited)




      Operating Income (loss) from Continuing Operations




      Three Months Ended




      September 30,
      2020



      June 30,

      2020



      September 30,
      2019


      GAAP reported


      $

      11,331



      $

      (2,567)



      $

      31,207


      Inventory write-down 1



      —




      9,932




      —


      Cost reduction and other charges



      —




      3,415




      —


      Foreign exchange losses (gains)



      982




      (98)




      569


      Excluding specific items


      $

      12,313



      $

      10,682



      $

      31,776






      Income (loss) from Continuing Operations




      Three Months Ended




      September 30,
      2020



      June 30,

      2020



      September 30,
      2019


      GAAP reported


      $

      2,996



      $

      (5,675)



      $

      24,210


      Inventory write-down 1



      —




      9,495




      —


      Cost reduction and other charges



      —




      3,265




      —


      Debt issuance cost write-off



      —




      328




      —


      Debt restructuring



      1,223




      —




      —


      Impact of higher (lower) tax rate 2



      2,773




      (1,208)




      (2,172)


      Foreign exchange losses (gains)



      344




      (79)




      455


      Excluding specific items


      $

      7,336



      $

      6,126



      $

      22,493






      Earnings (Loss) Per Diluted Share from Continuing Operations




      Three Months Ended




      September 30,
      2020



      June 30,

      2020



      September 30,
      2019


      GAAP reported


      $

      0.07



      $

      (0.13)



      $

      0.54


      Inventory write-down 1



      —




      0.21




      —


      Cost reduction and other charges



      —




      0.07




      —


      Debt issuance cost write-off



      —




      0.01




      —


      Debt restructuring



      0.03




      —




      —


      Impact of higher (lower) tax rate 2



      0.06




      (0.02)




      (0.05)


      Foreign exchange losses



      —




      —




      0.01


      Excluding specific items


      $

      0.16



      $

      0.14



      $

      0.50















      (1) Three months ended June 30, 2020 includes inventory write-down charge of $9.9 million, pretax.


      (2) Includes adjustments to reflect tax expense at a normalized rate of 20%.


      Segment Information

      (amounts in thousands)

      (Unaudited)




      Operating Income (Loss) from Continuing Operations




      Three Months Ended September 30, 2020




      Reservoir
      Description



      Production
      Enhancement



      Corporate and
      Other


      GAAP reported


      $

      11,022



      $

      (321)



      $

      630


      Foreign exchange losses



      696




      275




      11


      Excluding specific items


      $

      11,718



      $

      (46)



      $

      641



      Return on Invested Capital

      Return on Invested Capital ("ROIC") is based on Bloomberg's calculation on the trailing four quarters from the most recently reported quarter and the balance sheet of the most recent reported quarter, and is presented based on our belief that this non-GAAP measure is useful information to investors and management when comparing our profitability and the efficiency with which we have employed capital over time relative to other companies. ROIC is not a measure of financial performance under GAAP and should not be considered as an alternative to net income.

      ROIC is defined by Bloomberg as Net Operating Profit (Loss) ("NOP") less Cash Operating Tax ("COT") divided by Total Invested Capital ("TIC"), where NOP is defined as GAAP net income before minority interest plus the sum of income tax expense, interest expense, and pension expense less pension service cost and COT is defined as income tax expense plus the sum of the change in net deferred taxes, and the tax effect on interest expense and TIC is defined as GAAP stockholder's equity plus the sum of net long-term debt, allowance for doubtful accounts, net balance of deferred taxes, income tax payable, and other charges.

      Reconciliation of ROIC

      (amounts in millions, except for ROIC and WACC data)

      (Unaudited)




      Bloomberg



      Effect of non-cash
      charges



      Excluding non-cash
      charges


      Net operating profit


      $

      (59.5)



      $

      132.6



      $

      73.1


      Cash operating taxes



      42.6




      8.8




      51.4


      Total invested capital



      381.3




      126.7




      508.0















      Return on invested capital



      (26.8)

      %


      NM




      4.3

      %

      Weighted average cost of capital



      7.7

      %









      Free Cash Flow

      Core uses the non-GAAP measure of free cash flow to evaluate its cash flows and results of operations. Free cash flow is an important measurement because it represents the cash from operations, in excess of capital expenditures, available to operate the business and fund non-discretionary obligations. Free cash flow is not a measure of operating performance under GAAP, and should not be considered in isolation nor construed as an alternative consideration to operating income, net income, earnings per share, or cash flows from operating, investing, or financing activities, each as determined in accordance with GAAP. Free cash flow should not be considered a measure of liquidity. Moreover, since free cash flow is not a measure determined in accordance with GAAP and thus is susceptible to varying interpretations and calculations, free cash flow as presented may not be comparable to similarly titled measures presented by other companies.

      Computation of Free Cash Flow

      (amounts in thousands)

      (Unaudited)




      Three Months Ended



      Nine Months Ended





      September 30, 2020



      September 30, 2020



      Net cash provided by operating activities


      $

      20,693



      $

      69,714



      Capital expenditures



      (2,172)




      (8,578)



      Free cash flow


      $

      18,521



      $

      61,136



      SOURCE Core Laboratories N.V.

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.